To test the applicability of the All-in-One Cas9D10A nickase vector system and screening approaches in other cell lines, we targeted the DDR genes MDC1, 53BP1 and RIF1 in human aneuploid osteosarcoma (U2OS) cells and haploid chronic myelogenous leukaemia derived (HAP1) cells. This evidence concerns the gene TP53BP1 and chronic myelogenous leukemia, BCR-ABL1 positive.